E&C Announces Hearing on Interagency Proposal to Regulate Fentanyl-Related Substances
Energy and Commerce Chairman Frank Pallone, Jr. (D-NJ) and Health Subcommittee Chairwoman Anna G. Eshoo (D-CA) announced today that the Health Subcommittee will hold a hearing on Thursday, December 2, at 10:30 a.m. (EST) in the John D. Dingell Room, 2123 of the Rayburn House Office Building. The hearing is entitled, “The Overdose Crisis: Interagency Proposal to Combat Illicit Fentanyl-Related Substances.”
“The COVID-19 pandemic has tragically accelerated the overdose epidemic. Since the beginning of the pandemic more than 100,000 lives have been lost to drug overdoses, inflicting a tremendous toll on American families,” Pallone and Eshoo said. “It’s clear that more must be done to help Americans struggling to overcome substance use disorder and to reduce the supply of illicitly-manufactured fentanyl that is driving the overdose epidemic. Next week, the Health Subcommittee will hear from Biden Administration public health and law enforcement officials as we consider the interagency proposal to regulate fentanyl-related substances.”
This will be a hybrid hearing that includes both in person and remote member attendance via Cisco Webex video conferencing. Members of the public may view the hearing via live webcast accessible on the Energy and Commerce Committee’s website. Please note the webcast will not be available until the hearing begins.
The Committee strongly recommends that members of the media view the proceedings remotely. The Capitol and House Office Buildings currently have restricted access. Seating in the Committee room for credentialed media is very limited. Media must RSVP to their respective press gallery no later than 5 p.m. on Wednesday, December 1.
House Radio/TV Gallery:
House Periodical Gallery:
House Daily Press Gallery:
Information for this hearing, including the Committee Memorandum, witnesses, testimony, and a live webcast will be posted HERE as they become available.